TGA Approval

REVOLADE eltrombopag 12.5mg film-coated tablet blister pack (236115)

ARTG ID

236115

ARTG Name

REVOLADE eltrombopag 12.5mg film-coated tablet blister pack

Sponsor

Novartis Pharmaceuticals Australia Pty Ltd

ARTG Date

March 30, 2016

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

Novartis Pharmaceuticals Australia Pty Ltd.

https://medical-cdn.nocode.com/drug_tga/f51291b870ac09c1fb957f1b7f471d63.pdf

Ingredient Name

eltrombopag olamine

Empowering clinical research with data-driven insights and AI-powered tools.

REVOLADE eltrombopag 12.5mg film-coated tablet blister pack (236115) - TGA 批准文号 | MedPath